Prezent Appoints Janet Dorling to Board to Advance AI in Biopharma

Prezent has appointed Janet Dorling to its Board of Directors, a move aimed at accelerating its AI initiatives in the biopharmaceutical industry, announced in a press release. Dorling, who has over 25 years of leadership experience, is currently a Senior Vice President at Gilead Sciences, a global biopharmaceutical company.

Dorling's expertise in the biotech and pharma sectors is expected to be instrumental as Prezent continues to develop its AI platform for business presentations. Her previous experience with Prezent's platform, including its AI agent Astrid, has shown significant improvements in communication efficiency and quality.

The appointment is part of Prezent's broader strategy to enhance organizational productivity by addressing communication challenges. The company recently raised $20 million in funding to expand its AI capabilities into new industries and geographies, further supporting its mission to streamline business communication.